What's actually launching
The University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has started deploying what it calls the largest mobile cancer-screening fleet in the country, as first reported by Radiology Business. Two low-dose CT coaches dedicated to lung cancer screening arrived in October 2026, with a third following shortly, according to UAMS's own announcement. Those three CT coaches are one half of the planned six-van fleet — the other three are breast-cancer MammoVans, so the full fleet splits evenly between lung and breast screening rather than being six lung-screening CT units. Each CT coach carries a Philips Incisive CT 5100 scanner with solar and battery power, and the program is funded by a $4 million appropriation from the US Department of Health and Human Services' Health Resources and Services Administration, championed by Sen. John Boozman.
The targeting logic is sound public health strategy: UAMS is using statewide maps of lung cancer incidence and mortality to route the vans to the counties that need them most. Arkansas loses roughly 2,000 people to lung cancer every year and ranks fifth nationally for lung cancer mortality and third for cigarette-smoking rates, per the same UAMS release — smoking accounts for nearly 90% of lung cancer cases. Screening-eligible residents are adults age 50–80 with at least a 20 pack-year smoking history who currently smoke or quit within the past 15 years, plus people with qualifying family history, radon/asbestos exposure, or COPD. As of January 1, Arkansas's Act 390 also requires Medicaid and commercial insurers to cover eligible screenings, removing a cost barrier on top of the distance barrier the coaches are built to close.
That distance barrier isn't unique to Arkansas. A study of small and rural hospitals in Oregon, published in the Annals of the American Thoracic Society, found that 78% of rural residents there live more than 30 minutes from a lung cancer screening center, compared with 17% of urban residents — see the summary in AuntMinnie's coverage. It's a single-state study, not a national census, but it's consistent with the distance barrier UAMS is targeting in Arkansas. Mobile coaches are a direct answer to that specific gap. Low-dose CT screening itself reduces lung cancer mortality by roughly 20% in trial populations, so moving the scanner closer to eligible smokers should translate into earlier-stage diagnoses and fewer deaths — assuming the rest of the pathway can keep up.
The part the access story leaves out
A CT coach produces a study the moment the exam finishes. It does not produce a radiologist. Nationally, only about 1 in 5 eligible adults currently gets screened, per American Cancer Society data reported by Respiratory Therapy — meaning any program that meaningfully improves uptake, like a three-coach CT fleet reaching high-mortality counties, is by design adding exam volume that the existing reporting workforce has not had to handle before.
That workforce was already stretched before the coaches rolled out. A 2026 Journal of the American College of Radiology analysis from the Harvey L. Neiman Health Policy Institute found that imaging turnaround times for Medicare beneficiaries rose 33.4% in 2024 alone, part of a 177% cumulative rise since 2014 — and that CT turnaround specifically climbed 381% over that decade, with an 11.6% increase in 2024, as covered by AuntMinnie. The researchers' own read was blunt: radiologists "may be operating at or near maximum capacity." A separate Neiman projection of the national radiologist supply through 2055 concluded the current shortage is likely to persist for decades absent a change in workforce growth or per-person imaging demand, per DOTmed's coverage of the study.
Rural screening programs compound this in a specific way: many small and rural hospitals route scans to a centralized reading radiologist at a larger, often urban facility rather than reading them on-site — the same pattern documented in the rural-access study above. A mobile fleet multiplies the number of counties a single CT truck can reach, but the images it generates still funnel back into that same centralized, already-stretched reading pool. More coaches means more studies arriving at the same bottleneck, not a proportional increase in the people available to read them.
Access expansion vs. reporting capacity, side by side
| Metric | Direction | What it means |
|---|---|---|
| Mobile lung-screening CT coaches (UAMS fleet) | 2 → 3 vans | More CT exams generated per week in historically underserved counties (plus 3 separate breast MammoVans) |
| National screening uptake | ~20% of eligible adults | Large headroom for growth as access barriers fall |
| CT imaging turnaround time, 2014–2024 | +381% | Reads are already taking far longer than a decade ago |
| Radiologist supply shortage | Projected through 2055 | No near-term relief on the headcount side |
Figures as reported in the sources cited throughout this article; see citations above and the Source line below.
Why this matters beyond one state
UAMS's fleet is not an isolated case — it's a template other HRSA-funded and health-system programs are likely to repeat, because the underlying access problem (distance to a scanner) is common to rural lung cancer screening everywhere. Every version of that template has the same shape: fix the acquisition side first, because a parked truck with a scanner is a fundable, photographable, politically popular capital project. Reporting capacity doesn't get the same ribbon-cutting, even though a screening program that finds more nodules without a faster path to a signed report just adds a longer wait for an answer on top of the longer drive it eliminated.
That gap matters clinically, not just operationally. Indeterminate nodules found on screening CT are followed on strict Lung-RADS surveillance intervals, and expert guidance treats delay in getting those follow-up reads as a real risk of allowing an early-stage cancer to progress before it's caught. A reporting pipeline that can't keep pace with a growing coach fleet doesn't just mean a slower letter home — it means the follow-up clock on a nodule starts later than it should.
Where AI-assisted reporting fits
The mismatch here isn't a radiologist competence problem; it's a volume-and-time problem, and that's the specific gap AI CT reporting is built to close. A foundation-model system can draft a structured report — Lung-RADS categorization, nodule measurements, comparison to prior exams — the moment a mobile-coach study lands, so the radiologist opens a ready-to-sign draft instead of a blank worklist. That compresses the distance between "scan acquired in a parking lot in rural Arkansas" and "signed result in the patient's chart," without changing who is accountable for that result: xAID's in-house radiologist reviews every preliminary, and the client's reading radiologist signs the final report. Capacity expansion on the acquisition side only pays off for patients if reporting capacity expands with it — and that's the half of this story mobile-fleet launch coverage tends to skip.
Frequently asked questions
What is the new mobile lung cancer screening fleet in Arkansas?
The University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute is deploying mobile low-dose CT coaches to screen for lung cancer in underserved and rural counties. Two coaches launched in October 2026, with a third following shortly, for a planned total of three lung-screening CT coaches. UAMS is also deploying three breast-cancer MammoVans, for a combined six-van fleet it describes as the largest mobile cancer-screening fleet in the US. The program is funded by a $4 million appropriation from the US Department of Health and Human Services' Health Resources and Services Administration, championed by Sen. John Boozman.
Who is eligible for mobile lung cancer screening?
Current USPSTF-aligned criteria generally cover adults age 50 to 80 with at least a 20 pack-year smoking history who currently smoke or quit within the past 15 years, as well as people with qualifying risk factors such as family history, radon or asbestos exposure, or COPD. Nationally, only about 1 in 5 eligible adults is actually screened each year, and access is worse in rural areas — a study of rural Oregon screening facilities found 78% of rural residents lived more than 30 minutes from a screening center versus 17% of urban residents.
Does more lung cancer screening capacity create a reporting bottleneck?
It can. Expanding scanner access increases the number of low-dose CT exams that need a radiologist read, but the radiologist supply is not expanding at the same pace. A 2026 Harvey L. Neiman Health Policy Institute analysis projects the current radiologist shortage will persist through at least 2055, and a companion JACR study found CT imaging turnaround times for Medicare beneficiaries rose 381% from 2014 to 2024, with an 11.6% jump in 2024 alone. Mobile screening often routes images back to a smaller pool of centralized readers, concentrating the added volume rather than spreading it.
How does AI-assisted reporting help mobile lung cancer screening scale?
AI CT reporting tools can draft a structured preliminary report the moment a scan lands — triaging normal exams, flagging nodules against Lung-RADS criteria, and giving the radiologist a ready-to-sign starting point instead of a blank worklist. That doesn't replace the radiologist; it compresses the time from scan acquisition to a signed report, which matters specifically when exam volume is rising faster than radiologist headcount, as it is with coach-based screening programs.
Source: Radiology Business, UAMS Winthrop P. Rockefeller Cancer Institute, Respiratory Therapy (ACS data), AuntMinnie (Annals of the American Thoracic Society), AuntMinnie (JACR turnaround-time study), and DOTmed (Neiman Health Policy Institute radiologist-supply projection). Figures are rounded as reported.